Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    VolitionRx

    MCap

    USD76m

    Last close

    USD0.81

    ▲ 0.14 (20.90%)

    Canyon Resources

    MCap

    AUD262m

    Last close

    AUD0.19

    ▲ 0.02 (12.12%)

    Immix Biopharma

    MCap

    USD51m

    Last close

    USD1.82

    ▲ 0.12 (7.06%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Respiri (ASX: RSH)

Last close As at 21/11/2024

0.03

— 0.00 (0.00%)

Market capitalisation

AUD25m

Respiri is an ASX-listed company developing SaaS diagnostic solutions to support respiratory health management. Its technology detects wheeze, a typical symptom of asthma, chronic obstructive pulmonary disease and respiratory disease, to provide an objective measure of airway limitation.

Latest Insights

View More

Healthcare | Update

Respiri — Access platform-led growth prospects ahead

Healthcare | Flash note

Respiri — Early onset of synergies from Access acquisition

Healthcare | Flash note

Respiri — Raise anticipated to fund the Access acquisition

Healthcare | Flash note

Respiri — wheezo to access a larger addressable market
Happy children launch a kite in the field at sunset. Little boy and girl on summer vacation
Visit Website

Sector

Healthcare

Balance Sheet

Forecast net debt (A$m)

0.7

Forecast gearing ratio (%)

26

Share Price Performance

Price Performance
% 1M 3M 12M
Actual 4.2 (19.4) (59.7)
Relative 1.8 (25.4) (62.0)
52 week high/low A$0.1/A$0.0

Financials

Edison Investment Research is terminating coverage on Respiri (RSH). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Y/E Jun Revenue (A$m) EBITDA (A$m) PBT (A$m) EPS (fd) (c) P/E (x) P/CF (x)
2022A 0.8 (6.2) (6.3) (0.87) N/A N/A
2023A 0.7 (5.4) (5.4) (0.67) N/A N/A
2024E 6.6 (1.7) (1.8) (0.20) N/A N/A
2025E 11.9 0.5 0.4 0.03 83.3 8114.2
Happy children launch a kite in the field at sunset. Little boy and girl on summer vacation

Flash note

Healthcare

Respiri — Trading recap highlights continued market traction

Flash note

Healthcare

Respiri — NC rollout to expand wheezo market potential

Flash note

Healthcare

Respiri — New funding to support commercial traction

Flash note

Healthcare

Respiri — Sixth in spate of new client wins
Happy children launch a kite in the field at sunset. Little boy and girl on summer vacation

Flash note

Healthcare

Respiri — Shorter pilot study, potentially faster roll-out

Flash note

Healthcare

Respiri — First primary care setting client win

Flash note

Healthcare

Respiri — Commercialization efforts gathering steam

Flash note

Healthcare

Respiri — Wheezo bags third client win in the US

Flash note

Healthcare

Respiri — First patient enrolled in the US RPM programme
Happy children launch a kite in the field at sunset. Little boy and girl on summer vacation

Flash note

Healthcare

Respiri — Focus on cost optimisation

Initiation

Healthcare

Respiri — Objective measures for better outcomes

edison tv

Healthcare

Respiri – executive interview

QuickView

Healthcare

Respiri — Wheezo to begin patient use in the US

QuickView

Respiri — NIHR funding to seek better outcomes